Related Experiment Video
Updated: Mar 29, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
mHealth applications for diabetes: User preference and implications for app development.
Nicholas Conway1, Iona Campbell2, Paula Forbes2
1University of Dundee, UK n.z.conway@dundee.ac.uk.
Mobile health (mHealth) apps show high acceptance among diabetes patients, but current engagement is low. Future development should involve users to improve functionality and clinical relevance for better diabetes self-care.
Area of Science:
- Digital Health
- Diabetes Management
- Health Services Research
Background:
- Rising diabetes prevalence necessitates sustainable, person-centered care models.
- The mobile health (mHealth) market for diabetes self-care is expanding, yet key features remain undefined.
- Understanding user preferences is crucial for effective mHealth app development.
Purpose of the Study:
- To assess diabetes patient opinions on mHealth app features.
- To inform the development of more effective and valued diabetes self-care applications.
- To identify barriers and facilitators for mHealth engagement in diabetes management.
Main Methods:
- A questionnaire was developed based on an analysis of existing diabetes mHealth apps.
- The questionnaire was distributed to 400 patients stratified by diabetes type and age.
- Responses were analyzed by subgroup, comparing preferences with current app functionalities.
Main Results:
- A 59% response rate was achieved; 62% of respondents owned smartphones.
- Smartphone users showed a high preference for mHealth (71%), but actual diabetes app usage was low (7%).
- Patients favored numerous potential features, with consistent preferences across different diabetes types.
Conclusions:
- mHealth acceptance is high among diabetes patients, contrasting with low current engagement levels.
- Incorporating stakeholders, particularly patients, in development driven by clinical needs can enhance mHealth engagement and functionality.
- Future mHealth strategies must bridge the gap between acceptance and active utilization for improved diabetes self-care outcomes.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes: Symptoms, Diagnosis, and Complications

